"10.1371_journal.pone.0130653","plos one","2015-06-25T00:00:00Z","Davide Colombi; Julien Dinkel; Oliver Weinheimer; Berenike Obermayer; Teodora Buzan; Diana Nabers; Claudia Bauer; Ute Oltmanns; Karin Palmowski; Felix Herth; Hans Ulrich Kauczor; Nicola Sverzellati; Michael Kreuter; Claus Peter Heussel","Department of Surgical Sciences, Section of Diagnostic Imaging at University of Parma, Parma, Italy; Translational Lung Research Centre (TLRC), Member of the German Center for Lung Research (DZL), Heidelberg, Germany; Department of Diagnostic and Interventional Radiology, University of Heidelberg, Heidelberg, Germany; Department of Clinical Radiology, University of Munich, Munich, Germany; Department of Pneumology, Iuliu Hatieganu University of Medicine and Pharmacy in Cluj-Napoca, Cluj-Napoca, Romania; Division of Medical and Biological Informatics (E130), German Cancer Research Center (DFKZ), Heidelberg, Germany; Department of Pneumology and respiratory critical care medicine, Center for interstitial and rare lung diseases, Thoraxklinik at University of Heidelberg, Heidelberg, Germany","Conceived and designed the experiments: DC JD FH HUK MK CPH. Performed the experiments: DC JD OW DN UO KP. Analyzed the data: DC JD TB NS MK CPH BO. Contributed reagents/materials/analysis tools: OW TB. Wrote the paper: DC HUK NS MK CPH.","Colombi D received a support for travel to meetings for the study from Intermune. Oltmanns U received payment for educational presentation from European Respiratory Society and fees for both meetings and presentation at congresses from Intermune. Palmowski K received meetings expenses from Intermune. Herth F is board member of Novartis, Astra Zeneca, Grifols, Berlin Chemie, Chiesi, Pulmonx, and PneumRx; he also received fees for lectures from the same companies. Kauczor HU is board member of Siemens; he also received fees for lectures and educational presentations from Bracco, Novartis, Siemens, Boehringer, and Bayer. Sverzellati N received fees for lectures and educational presentation from Intermune, Boeringher, Astrazeneca, Pfizer, and Chiesi. Kreuter M received a grant from Dietmar Hopp Stiftung; he is also a consultant for Intermune and he received fees for lectures and educational presentations from Boehringer and Intermune. Heussel CP is a consultant of Pfizer, Boheringer Ingelheim, Gilead, Intermune, and Fresenius; he also received research funding from Siemens, Pfizer, and Boheringer Ingelheim as well as fees for lectures from Gilead, MSD, Pfizer, Intermune, Boheringer Ingelheim, and Novartis. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. For the remaining authors no competing interests were declared.","2015","06","Davide Colombi","DC",14,FALSE,6,6,7,5,TRUE,TRUE,TRUE,1,"7",FALSE
